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ABStrAct
Hospital records of patients seen between 1999 and 2002 were carefully examined. A question-
naire was used to extract relevant information from the case records and clinical diagnosis was 
made using the ICD-10. Cases that had evidence of pre-existing psychiatric disorder, family his-
tory of mental illness or heavy use of alcohol and/or tobacco were excluded.
Out of 6,556 patients that were seen for the first time, 849 were drug-related cases and 601 of 
these were primarily cannabis users. A substantial number (83%) of these were young and present-
ed with severe psychopathologies. About 90% and 47% were diagnosed with psychotic disorders 
and dependence syndrome, respectively. It is concluded that cannabis use is associated with severe 
psychopathologies and constituted over 70% of demand for treatment.
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introDuction
Cannabis is the most commonly abused il-
licit drug in the world. Out of some 200 mil-
lion persons (or 5% of the world population 
aged 15 – 64) estimated to have used drugs 
in 2003/2004; 160.9 million (or 4% of world 
population aged 15 – 64) used cannabis. Can-
nabis use is associated with a variety of psy-
chotic symptoms and exacerbates those of 
schizophrenia (UNODC, 2007). The annual 
prevalence of use of cannabis, cocaine, the 
amphetamines and opioids (as % of the popu-
lation aged 15 – 64) in Nigeria in 2004 was 
13.8%, 0.5%, 1.1%, and 0.6%, respectively 
(UNODC, 2007). Cannabis is not indigenous 
to Nigeria and was probably introduced to the 
country during and after the Second World 
War by members of the Nigerian armed forces 
returning from the Middle East, Far East and 
North Africa (Asuni, 1964).
Cannabis is the primary drug of abuse of 
most persons treated for drug -related prob-
lems in Nigeria. It accounted for 85.7% of de-
mand for treatment in 2003 ((UNODC. 2007).
Comparable figures for opiates and cocaine 
were 3.7% and 0.6% respectively. Cannabis 
abuse-related problems were first reported in 
Nigeria in the 1960s.
Early studies include 16 case records of pa-
tients with cannabis-related psychosis seen at 
the neuropsychiatric hospital, Aro, Abeokuta, 
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Nigeria (Asuni, 1964); report that 15% of pa-
tients admitted to the same hospital in 1959 
–1960 were related to cannabis use (Lambo, 
1965). The same author reported that 20% of 
the outpatients seen for psychiatric manage-
ment at the University College Hospital, Iba-
dan, Nigeria were related to cannabis. Others 
include report of a steady increase in the per-
centage of patients admitted at the psychiatric 
hospital, Yaba, Lagos, Nigeria with a history 
of cannabis use from 8.1% of all admissions in 
1961 – 1962 to 21% in 1964 –1965 (Boroffka, 
1966); two cases of psychosis following in-
gestion of cannabis by a three and an eleven 
year old children (Binitie, 1975); comparison 
of 33 patients that presented with cannabis-
associated psychosis with 25 paranoid schizo-
phrenics in which it was noted that the clini-
cal features of the two groups were similar 
(Sijuwola,1986). This study could not substan-
tiate the existence of cannabis psychosis as an 
independent disorder.
In a study of case records of patients admitted 
for drug and alcohol – related problems in psy-
chiatric treatment facilities in the Northern and 
Southern parts of Nigeria, cannabis abuse was 
recorded for 77% of the patients in the Northern 
part of the country while 60.6% was recorded 
for the Southern based facilities (Ohaeri and 
Odejide, 1993). No details of cannabis – associ-
ated psychopathologies were provided. A study 
in which some details of symptom patterns as-
sociated with cannabis use were provided did 
not exclude cases with histories of psychiatric 
disorders (Imade and Ebie, 1991). The patient 
populations of these studies were limited and/or 
the studies did not provide adequate details of 
patterns of psychopathologies associated with 
cannabis abuse. The present study was designed 
to provide details of pattern of psychopatholo-
gies and their prevalence in a large number of 
patients treated for cannabis – related problems 
over a period of four years.
MethoDS 
location: The study was carried out in the psy-
chiatric hospital, Uselu, Benin City, Nigeria. The 
hospital is a 221 bedded psychiatric care facility 
and provides inpatient and outpatient mental 
health services. Benin City is the capital of Edo 
State, one of the 36 States in Nigeria. The hos-
pital serves as a referral and treatment centre for 
six of the thirty six states. It is adequately staffed 
with consultant psychiatrists, resident doctors, 
clinical psychologists, psychiatric nurses, social 
workers and other support staff. 
Sample: The hospital records for the period 
January 1999 – December, 2002 were re-
viewed. Drug – related cases were identified 
and those cases with evidence of psychiatric 
disorders prior to use of cannabis, family his-
tory of mental illness or heavy use of alcohol 
and/or tobacco and other drugs such as the am-
phetamines were excluded from the study.
instrument: A 76 – item questionnaire de-
signed in standard manner of history taking in 
psychiatry by the authors was used to extract 
relevant information from the case records. 
The information included socio-demographic 
characteristics, past medical history, drug use 
history, family history, pattern of psychopatho-
logical symptoms presentations and diagnosis. 
Others include duration of illness, hospitaliza-
tion when applicable, mode of management and 
follow-up of clinic attendance after first presen-
tation or after discharge from admission.
Procedure: The study was carried out retro-
spectively from April to December, 2004. The 
case records were first sorted in the records de-
partment with the help of the medical clerks. 
They were carefully examined by the psychia-
trists. Clinical diagnosis was carried out based 
on the ICD-10 (WHO, 1992). Permission to 
carry out the study was obtained from the Re-
view Board of the hospital.
Data analysis: Statistical Package for the So-
cial Sciences, version 11.0 (SPSS, 2001) was 
used to analyze for frequency counts, measure 
of central tendency and dispersion and partial 
Spearman Rho correlation analysis following 
the distribution of the sample at five percent 
level of statistical significance.
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reSultS
Socio-demographic Characteristics 
Table 1 shows that the cases were predomi-
nantly young, single males who had complet-
ed senior secondary education. There was no 
significant difference between the ages of both 
sexes (t = -1.41, df = 559, p = 0.16). Most of 
the cases were of the lower socioeconomic 
group and were unemployed.
Clinical characteristics
Out of the 6,556 patients that were seen for the 
first time, 849 (13%) were drug – related cases. 
Eighty four percent (712) of the drug cases were 
cannabis – related out of which 601 (70.8%) were 
primarily cannabis users. Half of the 601 cases 
(49.3%) used cannabis for less than one year, 
28% (168) used cannabis for one to five years, 
12% (72) of the cases used for five to ten years 
and 10.8% (65) of the cases used cannabis for 
more than ten years. Ninety – six percent (575) 
of the cases used cannabis by smoking, 1.7% 
(10) ingested cannabis orally (used it to prepare 
stew and other food items) and 2.7% (16) of the 
cases smoked and ingested cannabis. 
Pattern of psychopathology presentations and 
clinical psychiatric diagnoses
Tables 2 and 3 show the pattern of psycho-
pathology presentations and clinical psychiat-
ric diagnoses among the cases, respectively.
The mean duration of hospitalization for 
those admitted was 6.91 weeks with a standard 
deviation of 3.90.
There was a moderate significant correlation 
between admission at first presentation and the 
number of relapse (Spearman Rho correlation, 
r = 0.58, p < 0.01, details not shown). 
For all the cases, there was a low significant 
positive correlation between age and the dura-
tion of cannabis use (r = 0.31, p < 0.01).
There was a little significant negative cor-
relation between ages of the cases and depen-
dence due to cannabis use (r = - 0.20, p< 0.01) 
which did not change after controlling for sex 
following a partial correlation, N = 507, r = - 
0.22, p < 0.01.
table 1. Sociodemographic 
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a:  includes welders, carpenters, auto mechanics, 
plumbers and electricians
b:  includes butchers, fishermen, motor bike operators.
In addition, there were low significant 
negative correlations between the duration of 
cannabis use and dependence syndrome (r = - 
0.31, p< 0.01), between the route of cannabis 
use and acute intoxication (r = - 0.15, p < 0.01) 
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table 2. Patterns of presentation of psychopathology




















































 Reduced appetite 
 Anxiety 







































a:  includes anxiety symptoms such as sensitivity to noise, worry thoughts, palpitations, chest discomfort, tremors, 
paraesthesia, dizziness, headache, flatulence, etc. affective symptoms such as extravagant spending, over familiarity, 
marked increase in sexual energy or indiscretion, marked loss of libido, ideas of guilt, reduced self-esteem and 
thoughts of suicide or suicidal behaviours.
































a: multiple diagnosis was recorded for some cases. The difference between the actual total is due to multiple diagnosis. 
and a low significant positive correlation be-
tween the route of cannabis use (smoking) 
and psychotic disorders (r = 0.15, p < 0.01). 
A large number of the cases presented with 
significant psychotic, schizophrenia-like and 
other psychiatric symptoms.
DiScuSSion
A review of the hospital records at the psy-
chiatric hospital, Uselu, Benin City in southern 
Nigeria between January 1999 and December, 
2002 showed that 13% (849) of the 6,556 pa-
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tients who presented (first seen ) for manage-
ment were drug - related cases. This figure is 
much higher than that reported for southern 
part of Nigeria in 1989 (Ohaeri and Odejide, 
1993). Further, eighty four percent (712) of the 
drug cases were cannabis related and 70.8% 
(601 cases) used cannabis as the primary drug 
of abuse.
The estimated treatment demand for can-
nabis associated problems (primary drug of 
abuse) in Nigeria in 2003 was 85.7% (UN-
ODC, 2007). There appears therefore to be a 
steady increase in the demand for treatment of 
cannabis use – related cases (see also Boroff-
ka, 1966). Young adults between the ages of 
20 and 29 represented 74.8% (450) of the cas-
es, most of who were of low socioeconomic 
background and unemployed (table 1).
Patterns of psychopathology presentation 
and psychiatric diagnoses are shown in tables 
2 and 3, respectively; Psychotic disorders 
were diagnosed for a very large proportion of 
the cases (89.9%, table 3). The proportion di-
agnosed for dependence syndrome was 47.1% 
(table 3). The present study shows that a sig-
nificant proportion of the cases were diagnosed 
with severe psychiatric disorders. 
Earlier reported studies of cases of canna-
bis-associated psychotic disorders in Nige-
ria involved much fewer patients and/or the 
symptoms reported were not as detailed as in 
the present study (see Asuni, 1964, Lambo, 
1965, Boroffka, 1966, Binitie, 1975, Sijuwola, 
1986, Imade and Ebie, 1991 and Anumonye, 
1980). There was no indications in these ear-
lier studies that patients with history of mental 
disorders or use of other drugs were excluded. 
Globally, there are several reports of psycho-
sis following use of cannabis (see for exam-
ple, Chopra and Smith, 1974, Andreason et 
al,.1987, Hall and Dagenhardt, 2000, Dennis 
et al., 2002, Henquet, et al., 2005, Ferguson et 
al., 2006 ). 
In contrast, a few studies did not find clear 
association between cannabis use and psycho-
sis (see Imade and Ebie, 1991, Thornicroft, 
Meadows and Politip, 1992). There is now a 
general agreement that cannabis use is asso-
ciated with psychosis but there is still debate 
on whether cannabis use causes psychoses or 
precipitates it in susceptible persons (Arse-
neault et al, 2004). However, it is important to 
observe that the use of cannabis carries a risk 
of psychiatric morbidity. Whether this risk is 
higher if the user is predisposed to psychiatric 
disorders is secondary to the fact that the use 
of cannabis has potential of resulting in seri-
ous mental problems.
Cannabis grows wild in many parts of Nige-
ria, in particular the Mid West (Edo and Delta 
States) and the South West (Ondo and Osun 
States). It is very cheap compared to other sub-
stances of abuse, including alcohol. For exam-
ple, the cost of one wrap of cannabis cigarette 
in Benin City is about 8 US cents. A bottle of 
popular locally produced beer of 600ml (5.1% 
volume alcohol content) costs equivalent of 
one US dollar. Because of its availability and 
low cost, regular cannabis users in Nigeria 
tend to use it heavily. Cannabis is usually sold 
in “bundles” (a bundle weighs 6-10 grams de-
pending on the quality). Five to seven wraps of 
cigarette are prepared from a bundle.
In an attempt to obtain information on the 
pattern of use of cannabis, ten of the patients 
with cannabis-related problems who presented 
at the hospital for management during this 
study were randomly selected and carefully 
interviewed about their use of cannabis. Use 
of cannabis by these patients ranged between 
14 and 42 wraps per week with a mean of 14 
wraps per week Four of them indicated that 
they started using cannabis before they were 
15 years old. The ten patients stated that the 
complaints of their parents, siblings and / or 
friends about their drug use habits led to their 
visit to the hospital (details not shown).
A possible reason for the rarity of “cannabis 
psychosis” in Western societies is that can-
nabis psychosis probably occurs after periods 
of its sustained heavy use (Hall and Dagen-
hardt, 2000). A search of cannabis literature 
did not provide a standard description of its 
“heavy use”. For example, heavy use has vari-
ously been described as more than 10 times 
per month (Kendler et al,. 2000); more than 
40 times without specification of what period 
(Miller and Plant, 2002); more than 50 times 
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without indication of what period (Zammit et 
al., 2002). Although lifetime use of cannabis 
has increased in Western Societies, the pat-
tern of heavy use is probably not as intense 
and common as in societies where it is readily 
available and very cheap. Although presence 
of cannabinoid in urine or blood was not es-
tablished in the cases of the present study, evi-
dence of cannabis use relied strongly on clini-
cal signs and symptoms of cannabis stigmata 
and careful history taking of the patients’ drug 
use. Self and informants’ reports of cannabis 
use provide additional confirmation of its use 
(Woody and MacFadden, 1995).
In any case, absence of cannabis in blood 
or urine does not necessarily prove that can-
nabis is not implicated in the psychopathol-
ogy and vice versa. For example, alcohol 
– related hallucinations can persist for weeks 
with no detectable amount of alcohol in the 
blood (Hall, 1988). Abuse of stimulants such 
as the amphetamines is very low in Nigeria 
(UNODC, 2007) and most of the cases stud-
ied were unemployed and possibly could not 
afford the cost of such other drugs which are 
much more expensive than cannabis in Nige-
ria. Despite the imperfections and uncertain-
ties of the available epidemiological evidence, 
acute intoxication and chronic use of cannabis 
appear to be associated with negative conse-
quences and substantial health burden (Hall 
and Babor, 2000).
There is now considerable evidence that 
indicate consistent association between can-
nabis use and psychotic disorders independent 
of confounding and transient intoxication ef-
fets (Moore et al,. 2007). The present study 
has provided substantial additional detailed 
evidence of severe psychopathology associ-
ated with cannabis use in a large number of 
patients in Nigeria.
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